BioPharma, Pharma Novartis Extends Its Reach in Radiopharmaceuticals With $1B Mariana Oncology Acquisition By Frank Vinluan
BioPharma, Pharma Ono Pharma’s Plan to Become a Global Player Picks Up a New Piece With $2.4B Deciphera Acquisition By Frank Vinluan
BioPharma, Diagnostics Labcorp Makes Another Acquisition, Plucking Invitae Assets From Bankruptcy Auction By Frank Vinluan
BioPharma, Pharma Vertex Pharma Bolsters Immunology Profile With $4.9B Alpine Immune Sciences Acquisition By Frank Vinluan
BioPharma, Pharma AbbVie Gets Another Ulcerative Colitis Contender via $137M Landos Acquisition By Frank Vinluan
BioPharma, Pharma AstraZeneca Joins Radiopharma Deals Spree With $2B Fusion Acquisition By Frank Vinluan
BioPharma, Pharma AstraZeneca Acquisition Brings Drug to Fill a Rare Disease Gap Left by Takeda By Frank Vinluan
BioPharma, Pharma Gilead’s $4.3B CymaBay Acquisition Adds Liver Disease Drug Under FDA Review By Frank Vinluan
BioPharma, Pharma Novartis’s MorphoSys Acquisition Comes With Cancer Drugs & Antitrust Questions By Frank Vinluan
Consumer / Employer, Payers Cigna MA Sale to HCSC Could Still Clear Way for Humana Acquisition, Expert Says By Marissa Plescia
Devices & Diagnostics Boston Scientific Continues Buying Spree with $3.7B Axonics Acquisition By Katie Adams
BioPharma, Pharma J&J Joins the Cancer ADC Dealmaking Spree With $2B Ambrx Acquisition By Frank Vinluan
BioPharma, Pharma Roche Lines Up $2.7B Acquisition to Join Chase for New Diabetes, Obesity Drugs By Frank Vinluan
